ICYMI, this week we had news about Winter Clinical Hawaii data, FDA updates to dupilumab's label to include hand and foot AD involvement, the phase 1 trial of EVO756 for adults with chronic spontaneous urticaria, and more.
The promising results were presented in a poster at the 2024 Winter Clinical Hawaii Dermatology Conference in Honolulu, Hawaii.
Data from Arcutis’ STRATUM study was presented at the 2024 Winter Clinical Hawaii Dermatology Conference.
The pooled analyses from Arcutis’ INTEGUMENT-1 and INTEGUMENT-2 studies were presented at the 2024 Winter Clinical Hawaii Dermatology Conference.
Additional studies are needed to adopt preventative measures and identify patients who may be deemed "at risk."
Placental tissues provide a promising alternative for addressing cutaneous reconstruction while maintaining the most cosmetically pleasing outcome.
This week’s collection of the latest dermatologic studies covers the association between smoking and male pattern hair loss, immunohistochemical expression of angiotensin-converting enzyme-2 in the skin of patients with COVID-19, stiff skin syndrome, and pityriasis rosea and pityriasis rosea-like eruption following COVID-19 vaccination.
A recent retrospective cohort study described drug survival and treatment patterns among patients with newly-diagnosed generalized pustular psoriasis.
The novel topical anticholinergic/antimuscarinic will offer an additional strategy for the treatment of underarm hyperhidrosis.
Seemal Desai, MD, highlighted the challenges and opportunities to best serve patients seeking solutions for acne scars, melasma, vitiligo, and cosmetic concerns.
Emmy Graber, MD, MBA, shared the truth behind cosmeceutical trends that patients may ask about from snail mucin to skin care refrigerators.
The FDA has added efficacy and safety data for patients ages 12 years and older with uncontrolled moderate-to-severe atopic dermatitis with hand and/or foot involvement.
The Winter Clinical Hawaii session delved into a spectrum of skin conditions, treatments, and common practice challenges.
This article will highlight recently approved psoriasis therapies that will shape the 2024 treatment landscape and provide some exciting updates in the psoriasis management market this coming year and beyond.
A hand-held skin fluorescence imaging system shows promise in its ability to differentiate between concerning and non-concerning moles.
Factors such as nutritional compromise, low levels of vitamin D, and more, negatively affect bone metabolism in this patient population.
A study found that combining dermoscopy with RCM not only improved diagnostic accuracy but also improved diagnostic certainty.
The skin’s microbiome becomes more diverse with age, and this diversity correlates with crow’s feet lines, according to new research.
Alopecia areata is more prevalent in non-White patients, according to findings of a recent study.
In this month’s Cosmetic Conundrums article, Zoe Diana Draelos, MD, reviews 5 popular social media dermatology trends for dermatology clinicians to be aware of.
The study suggests a relationship between an imbalance in the skin microbiota and LS-associated hypopigmentation.
The study explored the potential role of hormonal changes, specifically estrogen levels, in the pathogenesis of rosacea.
New evidence identifies factors that may predict which patients with psoriasis will develop psoriatic arthritis.
High-dose vitamin D helped improve radiation- and chemotherapy-induced skin injury in two patients undergoing cancer therapy.
SXRT may present a cost-effective and surgery-free therapeutic option for patients with non-aggressive BCC and SCC.
This data builds upon data of the READY-1 and READY-2 trials, wherein relabotulinumtoxinA's duration of effect was validated.
The study will evaluate the MRGPRX2 antagonist in healthy adults and adults with CSU.
Vd1-gd T cells, a rare type of immune cell, have been found to potentially predict how likely it is that certain patients with advanced skin cancer will be responsive to treatment via immunotherapy, according to recently published research.
In this week’s Pointers With Portela, the 208SkinDoc compares Accutane to 5 Aminolevulinic acid with red light therapy.
The hand-held DermaSensor uses an AI algorithm to noninvasively evaluate suspicious skin lesions for cancer.
A recent study explored the risk of skin cancer faced by patients undergoing phototherapy without psoralens.
Click here to answer this week's conference poll.
Among the many sessions to be held at the Maui Derm Hawaii 2024 conference on Maui, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.
The high-concentration and citrate-free biosimilar was first available in a single 40 mg dose.
The 40-GEP test could help patients with skin cancer avoid adjuvant radiation therapy while simultaneously saving millions in health care costs.
To stay up-to-date with the latest dermatology news, sign up to receive our eNewsletters.